entertainment -WSS

entertainment

author：knowledge 2025-10-04 07:08:24 Page View：75597

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heat waves linked to early deliveries, preterm births in new study
Next article： Medical leaders decry Supreme Court decision on affirmative action

focus

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Novo Nordisk testing Wegovy against alcohol

AdobeNovoNordiskwilltestwhetheritsGLP-1drugscanhelppeoplewithalcohol-associatedliverdisease,and,aspa

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

Antibiotic resistance nearly killed me, so I'm raising awareness of it

AdobeTherearemanyreasonswhypeoplewriteabouttheloomingthreatofantibioticresistance.Academicsdoittosha

entertainment

explore

focus

Antibiotic resistance nearly killed me, so I'm raising awareness of it